Phase 3 was completed in November 2023 and we reached our goal to fully sample 20,000 participants to help us identify the biological determinants of persistent nasal carriage of Staphylococcus aureus in humans. In total we had 26,584 people join the study and 20,896 of you went on to provide a full sample set.